Boehringer Ingelheim Animal Health has announced a change to the datasheet for Mamyzin, its antibiotic treatment for bovine mastitis.

The milk withdrawal has been reduced from 108 hours to 96 hours and the dose is now 15 mg/kg for three consecutive days…

Boehringer Ingelheim Animal Health has announced that its BRD vaccines, Bovalto Respi 3 and Bovalto Respi 4, are now licensed for use in pregnant cows.

Bovalto Respi 3 contains strains of parainfluenza virus 3, bovine respiratory syncytial virus and…

Boehringer Ingelheim - maker of Bovela - has announced the results of the 3rd annual BVD Survey, which has found amongst other things that 85% of respondents hadn't restarted a vaccination course when most of them should have.

1,219 farmers took part…

A group of seven European experts in bovine mastitis have issued a statement recommending that all cows on all farms should have an internal teat sealant administered at drying off.

The group, which was convened by Boehringer Ingelheim, made its recommendation…

Boehringer Ingelheim has launched Bovalto Respi Intranasal, an intranasal pneumonia vaccine for calves.

Bovalto Respi Intranasal protects against the two main respiratory viruses – RSV and PI3, using modified live viral strains that have been shown…

Boehringer Ingelheim's fourth National BVD Survey has found that 47% of farmers across the UK say veterinary advice was the main reason for their decision to vaccinate.

1243 farmers took part in the survey, which was held in partnership with the 

Boehringer Ingelheim, manufacturer of Bovikalc and Bovikalc Dry, has launched its National Milk Fever (hypocalcaemia) Survey and is asking vets to encourage their farm clients to take part and improve the quality of data available on clinical and subclinical…

Boehringer Ingelheim Animal Health has launched Ubropen (benzylpenicillin procaine monohydrate), an intramammary suspension containing 600mg of Procaine penicillin.

The company says that the composition and dosage of the new product has been optimised…

Boehringer Ingelheim is holding two free webinars looking at improving the control of mastitis on farms.

The first, 'Factors that determine the success of a mastitis treatment' is tomorrow, Thursday 30th April, at 7:30pm. It will be presented by veterinary…

DEFRA has granted a permit allowing the use of Bultavo 3, Boehringer Ingelheim's new vaccine against bluetongue virus serotype 3 in sheep and cattle. 

The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting…